Effects of hexoprenaline on the lecithin/sphingomyelin ratio and pressure-volume relationships in fetal rabbits.
A placebo-controlled, double-blind trial was carried out on 74 New Zealand White rabbit fetuses from 15 does to assess the effect of a fetal injection of hexoprenaline on surfactant release. After the uterus was exposed, half the fetuses received 0.1 ml (0.25 microgram) of hexoprenaline injected intraperitoneally through the intact uterine wall; the other half received an equivalent volume of placebo. After 3 hours, the abdomen was reopened, and the fetuses were surgically delivered and killed before breathing. The lecithin/sphingomyelin (L/S) ratios, obtained from lung washings, revealed a mean of 1.59:1 for the placebo group and 1.92:1 for the hexoprenaline group (p less than 0.001). Pressure/volume curves were generated from the lungs of 24 fetuses from 10 does, and the volume of air in the lungs for each pressure was analyzed in four ways: total volume, volume per gram of fetal body weight, volume per gram of dry lung weight, and as a percentage of total lung capacity at a pressure of 40 cm H2O. A first and second inflation-deflation curve was obtained for each experiment. The lungs from the hexoprenaline-treated group retained significantly more air than those from the placebo group. The most significant comparison was obtained when lung volume was expressed per gram of dry lung weight. The possibility of administering a beta 2-sympathomimetic drug to the mother in advanced preterm labor, specifically to release surfactant in the fetal lung, is suggested.
D000653:Amniotic Fluid / Q000378:metabolism*; D000818:Animals; D004311:Double-Blind Method; D005260:Female; D006594:Hexoprenaline / Q000494:pharmacology*; D008168:Lung / Q000196:embryology; D008176:Lung Volume Measurements; D009929:Organ Size / Q000187:drug effects; D010627:Phenethylamines / Q000494:pharmacology*; D010713:Phosphatidylcholines / Q000378:metabolism*; D010919:Placebos; D011247:Pregnancy; D011312:Pressure; D011663:Pulmonary Surfactants / Q000378:metabolism; D011817:Rabbits; D013109:Sphingomyelins / Q000378:metabolism*
D010627:Phenethylamines; D010713:Phosphatidylcholines; D010919:Placebos; D011663:Pulmonary Surfactants; D013109:Sphingomyelins; D006594:Hexoprenaline